Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Solesence Inc. (SLSN:NASDAQ), powered by AI.
Solesence Inc. is currently trading at $1.36. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Solesence Inc. on Alpha Lenz.
Solesence Inc.'s P/E ratio is 53.4.
“Solesence Inc. trades at a P/E of 53.4 (premium valuation) with solid ROE of 11.0%.”
Ask for details →Solesence Inc. is a science-driven company specializing in the development and manufacture of mineral-based skincare and makeup products, with a particular focus on sun care and skin health. Originating from its predecessor, Nanophase Technologies Corporation, the company utilizes advanced materials engineering to create proprietary active pharmaceutical ingredients that deliver UV protection and environmental defense for the beauty and personal care sectors. Solesence partners with both global and independent brands, offering turnkey product development and custom solutions that emphasize clean, inclusive formulations. Its technological suite, including Active Stress Defense™, underpins a broad range of award-winning, patent-protected products recognized across the cosmetics industry. In addition to consumer-focused skincare formulations, Solesence also supplies engineered zinc oxide and titanium dioxide materials for use in sunscreens and other personal care applications. With manufacturing operations rooted in the United States and a strong commitment to quality, regulatory compliance, and innovation, Solesence plays a pivotal role in advancing mineral-based protection and skincare within the beauty market, supporting both established and emerging brands with expertise and scalability.
“Solesence Inc. trades at a P/E of 53.4 (premium valuation) with solid ROE of 11.0%.”
Ask for details →Solesence Inc. (ticker: SLSN) is a company listed on NASDAQ in the Consumer Defensive sector (Household & Personal Products). It has approximately 98 employees. Market cap is $96M.
The current price is $1.36 with a P/E ratio of 53.45x and P/B of 5.43x.
ROE is 10.99% and operating margin is 2.53%. Annual revenue is $62M.